208 related articles for article (PubMed ID: 22014472)
1. Factors affecting gynaecologists' decision to perform prophylactic oophorectomy concomitantly with hysterectomy: a Belgian survey.
Plusquin C; Fastrez M; Vandromme J; Rozenberg S
Maturitas; 2011 Dec; 70(4):391-4. PubMed ID: 22014472
[TBL] [Abstract][Full Text] [Related]
2. Determinants of the decision to perform prophylactic oophorectomy in association with a hysterectomy for a benign condition.
Plusquin C; Fastrez M; Vandromme J; Rozenberg S
Maturitas; 2012 Oct; 73(2):164-6. PubMed ID: 22964073
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
4. The RANZCOG College Statement on prophylactic oophorectomy in older women undergoing hysterectomy for benign disease: is the evidence sufficient to change practice?
Brand AH
Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):296-300. PubMed ID: 21806570
[TBL] [Abstract][Full Text] [Related]
5. Attitudes of Italian gynaecologists towards prophylactic oophorectomy at hysterectomy for non-malignant conditions.
Fuso L; Mazzola S; Ferrero A; Magistris A; Jacomuzzi ME; Carus AP; Dompè D; Marocco F; Logrippo V; Zola P
Eur J Obstet Gynecol Reprod Biol; 2006 Jan; 124(1):82-7. PubMed ID: 16026916
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
Schmeler KM; Sun CC; Bodurka DC; White KG; Soliman PT; Uyei AR; Erlichman JL; Arun BK; Daniels MS; Rimes SA; Peterson SK; Slomovitz BM; Milam MR; Gershenson DM; Lu KH
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):515-20. PubMed ID: 16946209
[TBL] [Abstract][Full Text] [Related]
7. Prevention of ovarian cancer: a survey of the practice of prophylactic oophorectomy by consultant gynaecologists in Ireland.
Geary M; Geoghegan A; Foley M
Ir Med J; 1997; 90(5):186-7. PubMed ID: 9345830
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the feasibility of bilateral salpingo-oophorectomy during vaginal hysterectomy for uterine prolapse.
Dain L; Abramov Y
Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):307-9. PubMed ID: 21806584
[TBL] [Abstract][Full Text] [Related]
9. Obstetrician-gynecologists' opinions on elective bilateral oophorectomy at the time of hysterectomy in the United States: a nationwide survey.
Harmanli O; Shinnick J; Jones K; St Marie P
Menopause; 2014 Apr; 21(4):355-60. PubMed ID: 23942250
[TBL] [Abstract][Full Text] [Related]
10. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.
Obermair A; Youlden DR; Baade PD; Janda M
Int J Cancer; 2014 May; 134(9):2211-22. PubMed ID: 24127248
[TBL] [Abstract][Full Text] [Related]
11. Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines.
Julian-Reynier C; Eisinger F; Moatti JP; Sobol H
Eur J Hum Genet; 2000 Mar; 8(3):204-8. PubMed ID: 10780786
[TBL] [Abstract][Full Text] [Related]
12. Physician opinions regarding elective bilateral salpingectomy with hysterectomy and for sterilization.
Gill SE; Mills BB
J Minim Invasive Gynecol; 2013; 20(4):517-21. PubMed ID: 23870241
[TBL] [Abstract][Full Text] [Related]
13. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries.
Ayhan A; Guvenal T; Salman MC; Ozyuncu O; Sakinci M; Basaran M
Gynecol Oncol; 2005 Aug; 98(2):235-41. PubMed ID: 15982725
[TBL] [Abstract][Full Text] [Related]
14. Predictors of successful salpingo-oophorectomy at the time of vaginal hysterectomy.
Karp DR; Mukati M; Smith AL; Suciu G; Aguilar VC; Davila GW
J Minim Invasive Gynecol; 2012; 19(1):58-62. PubMed ID: 22055729
[TBL] [Abstract][Full Text] [Related]
15. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011.
Mikhail E; Salemi JL; Mogos MF; Hart S; Salihu HM; Imudia AN
Am J Obstet Gynecol; 2015 Nov; 213(5):713.e1-13. PubMed ID: 25935772
[TBL] [Abstract][Full Text] [Related]
16. [Current surgical practice of prophylactic and opportunistic salpingectomy in France].
Chene G; de Rochambeau B; Le Bail-Carval K; Beaufils E; Chabert P; Mellier G; Lamblin G
Gynecol Obstet Fertil; 2016; 44(7-8):377-84. PubMed ID: 27363615
[TBL] [Abstract][Full Text] [Related]
17. Malignancies following bilateral salpingo-oophorectomy (BSO).
Gotlieb WH; Barchana M; Ben-Baruch G; Friedman E
Eur J Surg Oncol; 2006 Dec; 32(10):1231-4. PubMed ID: 16626923
[TBL] [Abstract][Full Text] [Related]
18. Oophorectomy in premenopausal women: health-related quality of life and sexual functioning.
Teplin V; Vittinghoff E; Lin F; Learman LA; Richter HE; Kuppermann M
Obstet Gynecol; 2007 Feb; 109(2 Pt 1):347-54. PubMed ID: 17267835
[TBL] [Abstract][Full Text] [Related]
19. Practice patterns of some gynaecologists in Malaysia with regards to prophylactic oophorectomy and hormone replacement therapy.
Ravindran J; Leow CH
Med J Malaysia; 1996 Dec; 51(4):409-14. PubMed ID: 10968026
[TBL] [Abstract][Full Text] [Related]
20. Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.
Villella JA; Parmar M; Donohue K; Fahey C; Piver MS; Rodabaugh K
Gynecol Oncol; 2006 Sep; 102(3):475-9. PubMed ID: 16473397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
